The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[3-(4-Benzothiazol-2-yl-benzyl)-4-oxo-3,4-dihydro-phthalazin-1-yl]-acetic acid ID: ALA414405
Chembl Id: CHEMBL414405
PubChem CID: 14810789
Max Phase: Preclinical
Molecular Formula: C24H17N3O3S
Molecular Weight: 427.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)Cc1nn(Cc2ccc(-c3nc4ccccc4s3)cc2)c(=O)c2ccccc12
Standard InChI: InChI=1S/C24H17N3O3S/c28-22(29)13-20-17-5-1-2-6-18(17)24(30)27(26-20)14-15-9-11-16(12-10-15)23-25-19-7-3-4-8-21(19)31-23/h1-12H,13-14H2,(H,28,29)
Standard InChI Key: PJXVPQIUWJKKNW-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 427.49Molecular Weight (Monoisotopic): 427.0991AlogP: 4.35#Rotatable Bonds: 5Polar Surface Area: 85.08Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.85CX Basic pKa: 2.03CX LogP: 4.74CX LogD: 1.60Aromatic Rings: 5Heavy Atoms: 31QED Weighted: 0.45Np Likeness Score: -1.68
References 1. Mylari BL, Larson ER, Beyer TA, Zembrowski WJ, Aldinger CE, Dee MF, Siegel TW, Singleton DH.. (1991) Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners., 34 (1): [PMID:1899452 ] [10.1021/jm00105a018 ]